Singular Genomics is working at the forefront of genomics and has created the world’s most powerful benchtop sequencer. The sequencer and Singular’s first commercial product, G4, is an innovative sequencing platform that delivers unmatched power, speed and versatility. G4 uses a proprietary 4-color Rapid SBS chemistry comprising engineered enzymes and nucleotides that enable highly accurate paired-read sequencing for multiple experiments in parallel. Besides G4, Singular is interested in developing tools for spatial multi-omics with single-cell resolution. Ultimately, Singular is focused on advancing science through offering powerful sequencing approaches.

<p>Singular Genomics is working at the forefront of genomics and has created the world’s most powerful benchtop sequencer. The sequencer and Singular’s first commercial product, G4, is an innovative sequencing platform that delivers unmatched power, speed and versatility. G4 uses a proprietary 4-color Rapid SBS chemistry comprising engineered enzymes and nucleotides that enable highly accurate paired-read sequencing for multiple experiments in parallel. Besides G4, Singular is interested in developing tools for spatial multi-omics with single-cell resolution. Ultimately, Singular is focused on advancing science through offering powerful sequencing approaches.</p>


Singular Genomics

Founded: 2016
Location: La Jolla, CA
Employee range: 200 - 500
Funding: $258M IPO May 2021

Short description:

Drug notes:

Long description:

Jobs: